Endoscopy July 2021 PMID 32698233

Narrow-band imaging versus Lugol chromoendoscopy for esophageal squamous cell cancer screening in normal endoscopic practice: randomized controlled trial.

Mélissa Gruner, Angélique Denis, Claude Masliah, Morgane Amil, Elodie Metivier-Cesbron, Dominique Luet, Medhi Kaasis, Emmanuel Coron, Marc Le Rhun, Stéphane Lecleire, Michel Antonietti, Jean-Louis Legoux, Laurent Lefrou, Pascal Renkes, Anne-Laure Tarreirias

Full text PDF Download social card

Mentions

Peak: 12 in Jun 2021

across 3 sources since Jun 2021

Extended reach

41,655

potential audience

Total likes

Video views

569

Mentions per month

Jun 2021 – Apr 2022

Where it's discussed

X / Twitter12 posts
Facebook2 posts
YouTube1 videos

AI synopsis

What people are saying

The overall tone indicates strong backing for the research, with posts describing NBI as a 'game-changer' in esophageal cancer screening, emphasizing its higher specificity and similar sensitivity to Lugol's, thus potentially improving routine clinical practice. Words like 'findings,' 'support,' and references to figures and podcasts demonstrate that the discussions are both informative and influential, highlighting the importance of the study in advancing medical screening methods.

AgreementStrong agreement

Most discussions highlight the study's findings that NBI is as sensitive but more specific than Lugol’s, showing strong support for the conclusions.

InterestHigh interest

The focus on advanced endoscopic techniques and the potential clinical implications generate high curiosity and relevance among professionals.

EngagementModerate engagement

Participants often reference specific figures and clinical applications, indicating active interest but not overly in-depth engagement.

ImpactHigh impact

The widespread sharing of the study and related media suggests it is perceived as influential, potentially shaping future screening practices.

Abstract in brief

The study found that Narrowband Imaging (NBI) is as sensitive as Lugol chromoendoscopy in detecting esophageal squamous cell carcinoma (SCC), but NBI has a higher specificity, meaning it better distinguishes actual cases from false positives, especially in general medical practice outside expert centers.
The trial involved 334 patients across multiple French centers, comparing diagnostic accuracy between the two methods; results showed NBI had a specificity of 79.9%, which was significantly higher than Lugol's 66.0%, with both methods achieving 100% sensitivity.
The study suggests that while NBI alone is effective, combining NBI with Lugol chromoendoscopy could further improve early SCC detection, although more research is needed to confirm this approach's benefits in routine clinical settings.

Read the full abstract

All mentions

Narrowband Imaging vs Lugol Chromoendoscopy for Esophageal Cancer Detection

This study compares Narrowband Imaging NBI and Lugol chromoendoscopy for esophageal squamous cell carcinoma detection, showing NBI has higher specificity while both methods have 100% sensitivity in routine practices.

endoscopythieme · Jun 24, 2021 333 views

NBI vs. Lugol chromoendoscopy for ESCC screening in normal endoscopic practice

endoscopythieme · Jun 24, 2021 236 views